TSHA ▲ +1.6% - Taysha Gene Therapies, Inc.
$TSHA reported Q3 2026 EPS of -$0.10, beating the -$0.13 estimate by 23.1%. Revenue of $0 missed the $618,180 estimate by 100.0%.
12-NOV-2026 07:35 AM ET
Share this post
More filings for $TSHA
TSHA ▲ +1.6% - Taysha Gene Therapies, Inc.Nov 12, 2026TSHA ▼ -0.2% - Taysha Gene Therapies, Inc.Oct 2, 2026TSHA ▼ -2.7% - Taysha Gene Therapies, Inc.Oct 1, 2026TSHA ▼ -2.3% - Taysha Gene Therapies, Inc.Sep 4, 2026TSHA - Taysha Gene Therapies, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026TSHA - Taysha Gene Therapies, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $TSHA filing history →💬 Comments
Loading comments…
Leave a comment